Similar articles for PMID: 26183297

Year	Number of Results
1955	1
1989	1
1990	1
1991	1
1994	1
1996	2
1997	1
1999	2
2000	4
2001	4
2002	4
2004	4
2005	6
2006	3
2007	6
2008	2
2009	5
2010	2
2011	5
2012	8
2013	6
2014	5
2015	12
2016	18
2017	13
2018	18
2019	15
2020	13
2021	17
2022	15
2023	4
2024	0

1

Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease.

San-Juan R, Navarro D, García-Reyne A, Montejo M, Muñoz P, Carratala J, Len O, Fortun J, Muñoz-Cobo B, Gimenez E, Eworo A, Sabe N, Meije Y, Martin-Davila P, Andres A, Delgado J, Jimenez C, Amat P, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Aguado JM; REIPI Network, Spain; GESITRA Study Group from the SEIMC. San-Juan R, et al. J Infect. 2015 Nov;71(5):561-70. doi: 10.1016/j.jinf.2015.06.013. Epub 2015 Jul 14. J Infect. 2015. PMID: 26183297

2

Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients.

San-Juan R, Navarro D, García-Reyne A, Montejo M, Muñoz P, Carratala J, Len O, Fortun J, Muñoz-Cobo B, Gimenez E, Eworo A, Sabe N, Meije Y, Martín-Davila P, Andres A, Delgado J, Jimenez C, Amat P, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Aguado JM; REIPI Network. San-Juan R, et al. Transpl Infect Dis. 2015 Oct;17(5):637-46. doi: 10.1111/tid.12417. Epub 2015 Aug 27. Transpl Infect Dis. 2015. PMID: 26134282

3

A new strategy of delayed long-term prophylaxis could prevent cytomegalovirus disease in (D+/R-) solid organ transplant recipients.

San Juan R, Yebra M, Lumbreras C, López-Medrano F, Lizasoain M, Meneu JC, Delgado J, Andrés A, Aguado JM. San Juan R, et al. Clin Transplant. 2009 Sep-Oct;23(5):666-71. doi: 10.1111/j.1399-0012.2009.01077.x. Epub 2009 Aug 17. Clin Transplant. 2009. PMID: 19689451

4

Impact of valganciclovir prophylaxis on the development of severe late-cytomegalovirus disease in high-risk solid organ transplant recipients.

Cervera C, Pineda M, Linares L, Marcos MA, Esteva C, Antón A, Cofán F, Ricart MJ, Navasa M, Pérez-Villa F, Pumarola T, Moreno A. Cervera C, et al. Transplant Proc. 2007 Sep;39(7):2228-30. doi: 10.1016/j.transproceed.2007.07.039. Transplant Proc. 2007. PMID: 17889146

5

Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.

Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC, Spivey JR, Paya CV. Razonable RR, et al. J Infect Dis. 2001 Dec 1;184(11):1461-4. doi: 10.1086/324516. Epub 2001 Oct 23. J Infect Dis. 2001. PMID: 11709790 Clinical Trial.

6

Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice.

Fernández-Ruiz M, Arias M, Campistol JM, Navarro D, Gómez-Huertas E, Gómez-Márquez G, Díaz JM, Hernández D, Bernal-Blanco G, Cofan F, Jimeno L, Franco-Esteve A, González E, Moreso FJ, Gómez-Alamillo C, Mendiluce A, Luna-Huerta E, Aguado JM; OPERA Study Group. Fernández-Ruiz M, et al. Transpl Int. 2015 Sep;28(9):1042-54. doi: 10.1111/tri.12586. Epub 2015 Apr 23. Transpl Int. 2015. PMID: 25864986 Free article.

7

Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.

Young PG, Rubin J, Angarone M, Flaherty J, Penugonda S, Stosor V, Ison MG. Young PG, et al. Transpl Infect Dis. 2016 Jun;18(3):390-5. doi: 10.1111/tid.12537. Epub 2016 Jun 9. Transpl Infect Dis. 2016. PMID: 27037651

8

Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients.

Limaye AP, La Rosa C, Longmate J, Diamond DJ. Limaye AP, et al. Transplantation. 2016 Jan;100(1):210-6. doi: 10.1097/TP.0000000000000816. Transplantation. 2016. PMID: 26680375 Free PMC article.

9

[Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].

Aranda-Verástegui F, Alberú J, Soto-Ramírez LE, González-Aguirre H, Muñoz Trejo T, Mancilla E, Díliz H, Correa-Rotter R, Sierra-Madero J. Aranda-Verástegui F, et al. Rev Invest Clin. 2002 May-Jun;54(3):198-203. Rev Invest Clin. 2002. PMID: 12183888 Spanish.

10

Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients.

La Rosa C, Limaye AP, Krishnan A, Blumstein G, Longmate J, Diamond DJ. La Rosa C, et al. Transpl Int. 2011 Sep;24(9):920-31. doi: 10.1111/j.1432-2277.2011.01285.x. Epub 2011 Jun 14. Transpl Int. 2011. PMID: 21672050 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

180 results

Results by year